| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5655919 | Digestive and Liver Disease | 2016 | 6 Pages |
Abstract
Concurrent use of proton pump inhibitors at the time of FIT might increase the likelihood of a false-positive result. Further investigation is needed to determine whether discontinuing them could decrease the false-positive rate.
Related Topics
Health Sciences
Medicine and Dentistry
Endocrinology, Diabetes and Metabolism
Authors
Gemma Ibáñez-Sanz, Montse Garcia, Francisco RodrÃguez-Moranta, Gemma Binefa, Javier Gómez-Matas, Xènia Domènech, Carmen Vidal, Antonio Soriano, VÃctor Moreno,